Featured
-
-
News & Views |
Nanotherapeutics for cardiovascular disease
Nanotherapies are emerging rapidly as options to treat cardiovascular disease. However, insufficient and heterogeneous delivery remain critical issues. Novel strategies to boost targeted delivery of systemically administered nanoparticles by optimizing the particle physical properties or using immune cells as carriers promise to increase nanotherapeutic effectiveness in cardiovascular and other inflammatory diseases.
- Bryan Ronain Smith
-
Research Highlight |
Macrophage mimetics to target atherosclerosis
A new biomimetic drug delivery system consisting of nanoparticles that are coated with macrophage membrane and responsive to reactive oxygen species enables targeted pharmacotherapy for atherosclerosis in mice while also suppressing local inflammation by sequestering inflammatory factors.
- Irene Fernández-Ruiz
-
Research Highlight |
Nanoimmunotherapy targeting CD40–TRAF6 signalling to reduce atherosclerosis
- Gregory B. Lim
-